Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer

Published in Science Immunology, 2021

Horton, B. L., Morgan, D. M., Momin, N., Zagorulya, M., Torres-Meija, E., Bhandakar, V., Wittrup, K. D., Love, J. C., Spranger, S. (2021). "Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer." Science Immunology. 6, abi8800 (2021). https://doi.org/10.1126/sciimmunol.abi8800